HYUNDAI BIOLAND Co.Ltd Total Liabilities
HYUNDAI BIOLAND Co.Ltd total liabilities. Based on the latest financial reports, HYUNDAI BIOLAND Co.Ltd (052260) has total liabilities worth ₩27.91 Billion KRW (≈ $18.91 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check financial resilience of HYUNDAI BIOLAND Co.Ltd to evaluate the company's liquid asset resilience ratio.
Total Liabilities of HYUNDAI BIOLAND Co.Ltd (2011–2024)
Total liabilities of HYUNDAI BIOLAND Co.Ltd from 2011 to 2024. This chart illustrates how HYUNDAI BIOLAND Co.Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore HYUNDAI BIOLAND Co.Ltd (052260) investment intensity to see how much of total assets are deployed in long-term investments.
HYUNDAI BIOLAND Co.Ltd Competitors by Total Liabilities
The table below lists competitors of HYUNDAI BIOLAND Co.Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Hotel Sahid Jaya Tbk
JK:SHID
|
Indonesia | Rp540.13 Billion |
|
Culp, Inc. Common Stock
NASDAQ:CULP
|
USA | $70.53 Million |
|
Respiri Ltd
AU:RSH
|
Australia | AU$2.26 Million |
|
CanAlaska Uranium Ltd
V:CVV
|
Canada | CA$7.08 Million |
|
Eureka Acquisition Corp Class A Ordinary Share
NASDAQ:EURK
|
USA | $33.20 Million |
|
Sinmah Capital Bhd
KLSE:9776
|
Malaysia | RM22.18 Million |
|
Inventus Mining Corp
V:IVS
|
Canada | CA$1.14 Million |
|
Eightco Holdings Inc.
NASDAQ:OCTO
|
USA | $40.18 Million |
Liability Composition Analysis (2011–2024)
This chart breaks down HYUNDAI BIOLAND Co.Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see how large is HYUNDAI BIOLAND Co.Ltd's balance sheet.
Liquidity & Leverage Metrics
HYUNDAI BIOLAND Co.Ltd Total Liabilities Ratios Explained
HYUNDAI BIOLAND Co.Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.51 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.20 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.17 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how HYUNDAI BIOLAND Co.Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for HYUNDAI BIOLAND Co.Ltd (2011–2024)
The table below shows the annual total liabilities of HYUNDAI BIOLAND Co.Ltd from 2011 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩56.72 Billion ≈ $38.44 Million |
+17.95% |
| 2023-12-31 | ₩48.08 Billion ≈ $32.59 Million |
+2.72% |
| 2022-12-31 | ₩46.81 Billion ≈ $31.72 Million |
-1.23% |
| 2021-12-31 | ₩47.39 Billion ≈ $32.12 Million |
-6.02% |
| 2020-12-31 | ₩50.43 Billion ≈ $34.18 Million |
-5.44% |
| 2019-12-31 | ₩53.33 Billion ≈ $36.14 Million |
+20.50% |
| 2018-12-31 | ₩44.26 Billion ≈ $29.99 Million |
+14.79% |
| 2017-12-31 | ₩38.55 Billion ≈ $26.13 Million |
+3.82% |
| 2016-12-31 | ₩37.14 Billion ≈ $25.17 Million |
+17.71% |
| 2015-12-31 | ₩31.55 Billion ≈ $21.38 Million |
+10.00% |
| 2014-12-31 | ₩28.68 Billion ≈ $19.44 Million |
-18.36% |
| 2013-12-31 | ₩35.13 Billion ≈ $23.81 Million |
-24.31% |
| 2012-12-31 | ₩46.41 Billion ≈ $31.45 Million |
+30.49% |
| 2011-12-31 | ₩35.56 Billion ≈ $24.10 Million |
-- |
About HYUNDAI BIOLAND Co.Ltd
HYUNDAI BIOLAND Co.,Ltd manufactures and sells raw materials for cosmetics, nutraceuticals, and regenerative medicines. It offers anti-aging, moisturizing, whitening, skin protection, and other cosmetic ingredients; functional food ingredients and general food raw materials; and active pharmaceutical ingredients. The company was formerly known as SKbioland Co., Ltd. and changed its name to HYUNDA… Read more